期刊文献+

药物诱发心律失常的性别差异及其电生理学基础 被引量:2

Electrophysiological basis underlying gender-related differences in drug-induced arrhythmias
下载PDF
导出
摘要 人的心脏复极化存在性别差异。女性药物诱发的心律失常的发生率远高于男性,而男性房颤和猝死的发生率远高于女性。此外,Brugada综合征、早复极综合征等的发生率也存在性别差异。大量研究结果表明性激素是心肌复极化性别差异的主要影响因素,在一定程度上,性激素通过影响几种主要的离子电流来影响复极化。本文综述了近年来对人类以及几种实验动物(家兔、小鼠、豚鼠)心脏复极时间和离子电流性别差异的研究,及性激素对心脏复极化的直接影响以阐明药物诱发心律失常性别差异的电生理学机制。 There are a number of gender differences in cardiac repolarization. The incidence of drug-induced arrhythmias in women is higher than that in men while the situation of the atrial fibrillation or sudden death is the opposite. Moreover, increasing evidence that gonadal To some extent, sex hormones sex differences exist in Brugada syndrome and early afterdepolarization. There is steroids are important determinants of gender differences in heart repolarization. regulate ion currents to affect repolarization. This review summarized recent advance on sex differences in heart repolarization and ion currents in human as well as in animals (rabbit, mouse and guinea pig) and the direct effects of sex hormones on repolarization in order to elucidate the electrophysiological mechanisms underlying the gender-related differences in drug-induced arrhythmias.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2008年第5期359-364,共6页 Chinese Journal of New Drugs and Clinical Remedies
关键词 心律失常 激素替代疗法 钾通道 钙通道 性别差异 复极化 arrhythmia hormone replacement therapy potassium channels calcium channels gender difference repolarization
  • 相关文献

参考文献31

  • 1ABI-GERGES N, PHILP K, POLLARD C, et al. Sex differences in ventricular repolarization: from cardiac electrophysiology to torsades de points[J]. Fundamental & Clinical Pharmacology, 2004, 18(2): 139-151. 被引量:1
  • 2NAKAGAWA M, TAKAHASHI N, WATANABE M, et al. Gender differences in ventricular repolarization: terminal T wave interval was shorter in women than in men[J]. Pacing Clin Electrophysiol, 2003, 26(12): 59-64. 被引量:1
  • 3BIDOGGIA H, MACIEL JP, CAPALOZZA N, et al. Sex differences on the electrocardiographic pattern of cardiac repolarization : possible role of testosterone[J]. Am Heart, 2000, 140(4): 678- 683. 被引量:1
  • 4成建华.非抗心律失常药的致心律失常作用及相关危险因子[J].中国新药与临床杂志,2004,23(10):713-718. 被引量:5
  • 5EL-ERAKY H, THOMAS SH. Effects of sex on the pharmacokinetic and pharmacodynamic properties of quinidine[J]. Br J Clin Pharmacol, 2003, 56(2): 198-204. 被引量:1
  • 6BENTON RE, SALE M, FLOCKHART DA, et al. Greater quinidine-induced QTc interval prolongation in women[J]. Clin Pharmacol, 2000, 67(4): 413-418. 被引量:1
  • 7RODRIGUEZ I, KILBRON M J, LIU XK, et al. Drug-induced QT prolongation in women during the menstrual cycle[J]. JAMA, 2001, 285(10) : 1322-1326. 被引量:1
  • 8KADISH AH, GREENLAND P, LIMACHER MC, et al. Estrogen and progestin use and the QT interval in postmenopausal women [J]. ANE, 2004, 9(4) : 366-374. 被引量:1
  • 9GOKCE M, KARAHAN B, YILMAZ R, et al. Long term effects of hormone replacement therapy on heart rate variability, QT interval, QT dispersion and frequencies of arrhythmia[J]. Int J Cardiol, 2005, 99(3): 373-379. 被引量:1
  • 10GOWA RM, KHAN IA, PUNUKOLLU G, et al. Female preponderance in ibutilide-induced torsade de points[J]. Int J Cardiol, 2004, 95(2/3) : 219-222. 被引量:1

二级参考文献40

  • 1[1]de PONTI F, POLUZZI E, MONTANARO N. QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience[J]. Eur J Clin Pharmacol, 2000, 56(1):1-18. 被引量:1
  • 2[2]de PONTI F, POLUZZI E, MONTANARO N. Organising evidence on QT prolongation and occurrence of Torsades de Pointes with non-antiarrhythmic drugs: a call for consensus[J]. Eur J Clin Pharmacol, 2001, 57(3):185-209. 被引量:1
  • 3[3]HAVERKAMP W, BREITHARDT G, CAMM AJ, et al. The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology[J]. Eur Heart J, 2000, 21(15):1216-1231. 被引量:1
  • 4[4]VISWANATHAN PC, SHAW RM, RUDY Y. Effects of IKr and IKs heterogeneity on action potential duration and its rate dependence: a simulation study[J]. Circulation, 1999, 99(18):2466-2474. 被引量:1
  • 5[5]VISWANATHAN PC, RUDY Y. Cellular arrhythmogenic effects of congenital and acquired long-QT syndrome in the heterogeneous myocardium[J]. Circulation, 2000, 101(10):1192-1198. 被引量:1
  • 6[6]RODEN DM. Taking the "idio" out of "idiosyncratic": predicting torsades de pointes[J]. Pacing Clin Electrophysiol,1998, 21(5):1029-1034. 被引量:1
  • 7[7]TAGLIALATELA M, TIMMERMAN H, ANNUNZIATO L. Cardiotoxic potential and CNS effects of first-generation antihistamines[J]. Trends Pharmacol Sci, 2000, 21(2):52-56. 被引量:1
  • 8[8]KANG J, WANG L, CHEN XL, et al. Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG[J]. Mol Pharmacol, 2001, 59(1): 122-126. 被引量:1
  • 9[9]TAGLIALATELA M, PANNACCIONE A, CASTALDO P, et al. Molecular basis for the lack of HERG K+ channel block-related cardiotoxicity by the H1 receptor blocker cetirizine compared with other second-generation antihistamines[J]. Mol Pharmacol, 1998, 54(1): 113-121. 被引量:1
  • 10[10]BISCHOFF U, SCHMIDT C, NETZER R, et al. Effects of fluoroquinolones on HERG currents[J]. Eur J Pharmacol, 2000, 406(3): 341-343. 被引量:1

共引文献4

同被引文献36

  • 1陈琪.ST段形态:早复极患者危险分层新指标[J].心电图杂志(电子版),2012,1(1):21-23. 被引量:5
  • 2成建华.非抗心律失常药的致心律失常作用及相关危险因子[J].中国新药与临床杂志,2004,23(10):713-718. 被引量:5
  • 3YAP YG, CAMM AJ. Induced Q-T prolongation and torsades de pointes[J]. Heart, 2003, 89(11 ) : 1363-1372. 被引量:1
  • 4LANKIPALLI RS, ZHU T, GUO D, et al. Mechanisms underlying arrhythmogenesis in long Q-T syndrome[J]. J Electrocardiol, 2005, 38(4 Suppl): 69-73. 被引量:1
  • 5ANTZELEVITCH C. Ionic, molecular, and cellular bases of Q- T-interval prolongation and torsade de pointes [J]. Europace, 2007, 9(4 Suppl): 4-15. 被引量:1
  • 6MILBERG P, HILKER E, RAMTIN S, et al. Proarrhythmia as a class effect of quinolones : increesed dispersion of repolarization and triangulation of action potential predict torsades de pontes[J]. J Cardiovasc Electrophysiol, 2007, 18(6) : 647-654. 被引量:1
  • 7HANCOX JC, MCPATE M J, EL HARCHI A, et al. The hERG potassium channel and hERG screening for drug-induced torsades de pointes[J]. Pharmcol Pharapeut, 2008,119(2): 118- 132. 被引量:1
  • 8OWENS RC Jr, NOLIN TD. Antimicrobial-associated Q-T interval prolongation: pontes of interert[J]. Clin Infect Dis, 2006, 43 (12): 1603-1611. 被引量:1
  • 9STANAT SJ, CARLTON CG, CRUMB WJ Jr, et al. Characterization of the inhibitory effects of erythromycin and clarithromycin on the HERG potassium channel[J]. Mol Cell Biochem, 2003, 254(1-2): 1-7. 被引量:1
  • 10VOLBERG WA, KOCI BJ, SU W, et al. Blockade of human cardiac potassium channel human ether-a-go-go-related gene (HERG) by macrolide antibiotics [J]. J Pharmacol Exp Ther, 2002, 302 (1) : 320-327. 被引量:1

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部